MARKEL GROUP INC (MKL)

US5705351048 - Common Stock

1568.66  -7.89 (-0.5%)

Fundamental Rating

4

Overall MKL gets a fundamental rating of 4 out of 10. We evaluated MKL against 141 industry peers in the Insurance industry. There are concerns on the financial health of MKL while its profitability can be described as average. MKL is quite expensive at the moment. It does show a decent growth rate.



5

1. Profitability

1.1 Basic Checks

MKL had positive earnings in the past year.
In the past year MKL had a positive cash flow from operations.
MKL had positive earnings in 4 of the past 5 years.
MKL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

MKL's Return On Assets of 3.57% is fine compared to the rest of the industry. MKL outperforms 74.29% of its industry peers.
MKL has a Return On Equity of 13.12%. This is in the better half of the industry: MKL outperforms 64.29% of its industry peers.
Industry RankSector Rank
ROA 3.57%
ROE 13.12%
ROIC N/A
ROA(3y)2.65%
ROA(5y)2.92%
ROE(3y)9.08%
ROE(5y)9.89%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MKL has a Profit Margin of 12.44%. This is in the better half of the industry: MKL outperforms 74.29% of its industry peers.
In the last couple of years the Profit Margin of MKL has grown nicely.
Looking at the Operating Margin, with a value of 18.53%, MKL is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Operating Margin of MKL has grown nicely.
Industry RankSector Rank
OM 18.53%
PM (TTM) 12.44%
GM N/A
OM growth 3Y3.42%
OM growth 5Y39.61%
PM growth 3Y16.35%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

MKL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MKL has been increased compared to 1 year ago.
The number of shares outstanding for MKL has been reduced compared to 5 years ago.
The debt/assets ratio for MKL has been reduced compared to a year ago.

2.2 Solvency

MKL has a debt to FCF ratio of 1.50. This is a very positive value and a sign of high solvency as it would only need 1.50 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 1.50, MKL is doing good in the industry, outperforming 61.43% of the companies in the same industry.
A Debt/Equity ratio of 0.25 indicates that MKL is not too dependend on debt financing.
MKL's Debt to Equity ratio of 0.25 is fine compared to the rest of the industry. MKL outperforms 70.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 1.5
Altman-Z N/A
ROIC/WACCN/A
WACC8.38%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

6

3. Growth

3.1 Past

The earnings per share for MKL have decreased strongly by -57.09% in the last year.
Measured over the past years, MKL shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.84% on average per year.
The Revenue has grown by 35.36% in the past year. This is a very strong growth!
MKL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.23% yearly.
EPS 1Y (TTM)-57.09%
EPS 3Y38.84%
EPS 5YN/A
EPS growth Q2Q-172.68%
Revenue 1Y (TTM)35.36%
Revenue growth 3Y17.53%
Revenue growth 5Y18.23%
Revenue growth Q2Q10.26%

3.2 Future

Based on estimates for the next years, MKL will show a very strong growth in Earnings Per Share. The EPS will grow by 26.13% on average per year.
Based on estimates for the next years, MKL will show a small growth in Revenue. The Revenue will grow by 4.62% on average per year.
EPS Next Y88.23%
EPS Next 2Y49.07%
EPS Next 3Y37.71%
EPS Next 5Y26.13%
Revenue Next Year2.35%
Revenue Next 2Y4.02%
Revenue Next 3Y5.15%
Revenue Next 5Y4.62%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 34.79, which means the current valuation is very expensive for MKL.
MKL's Price/Earnings ratio is a bit more expensive when compared to the industry. MKL is more expensive than 69.29% of the companies in the same industry.
MKL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 28.06.
MKL is valuated rather expensively with a Price/Forward Earnings ratio of 18.48.
Based on the Price/Forward Earnings ratio, MKL is valued a bit more expensive than the industry average as 65.71% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 20.72. MKL is around the same levels.
Industry RankSector Rank
PE 34.79
Fwd PE 18.48

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MKL indicates a somewhat cheap valuation: MKL is cheaper than 75.00% of the companies listed in the same industry.
MKL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 8.09
EV/EBITDA 6.46

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MKL's earnings are expected to grow with 37.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y49.07%
EPS Next 3Y37.71%

0

5. Dividend

5.1 Amount

MKL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MARKEL GROUP INC

NYSE:MKL (5/3/2024, 10:28:41 AM)

1568.66

-7.89 (-0.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap20.46B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 34.79
Fwd PE 18.48
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.57%
ROE 13.12%
ROCE
ROIC
ROICexc
ROICexgc
OM 18.53%
PM (TTM) 12.44%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-57.09%
EPS 3Y38.84%
EPS 5Y
EPS growth Q2Q
EPS Next Y88.23%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)35.36%
Revenue growth 3Y17.53%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y